Audited Results of Ankur Drugs & Pharma Ltd. Company

(Rs in Cr.)	Mar 31, 2012	Mar 31, 2011	Mar 31, 2010	Mar 31, 2009	Mar 31, 2008
Operating Income	151.49	824.85	1,067.66	965.75	673.73
Manufacturing Expenses	3.35	6.28	22.36	26.86	12.42
Personnel Expenses	18.80	20.44	17.94	5.19	8.63
Selling Expenses	0	0	2.41	2.26	0.63
Administrative Expenses	41.90	44.64	15.20	8.47	3.29
Expenses Capitalised	0	0	0	0	0
Cost Of Sales	179.39	690.95	858.47	785.96	566.39
Operating Profit	-27.90	133.90	209.19	179.79	107.33
Other Recurring Income	0.19	0.93	1.60	2.48	1.26
Adjusted PBDIT	-27.72	134.83	210.79	182.27	108.60
Financial Expenses	58.36	120.80	80.75	75.04	24.93
Depreciation	66.03	60.80	26.64	20.67	8.40
Other Write offs	0	0	0.13	0.12	0.26
Adjusted PBT	-152.11	-46.77	74.20	64.64	63.49
Tax Charges	19.02	22.04	29.07	21.80	11.51
Adjusted PAT	-171.13	-68.81	74.20	64.64	63.49
Non Recurring Items	-136.37	0	16.73	-27.52	0.01
Other Non Cash adjustments	0	0	-4.76	0.01	-0.75
Reported Net Profit	-307.49	-68.81	86.18	37.13	63.50
Equity Dividend	0	0	4.35	4.28	4.19
Preference Dividend	0	0	0	0	0
Retained Earnings	-243.68	63.81	182.62	121.57	99.45

Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article